Literature DB >> 3610371

Progression to end stage renal disease in post-streptococcal glomerulonephritis (PSGN)---Chandigarh Study.

K S Chugh, H S Malhotra, V Sakhuja, S Bhusnurmath, P C Singhal, V N Unni, N Singh, R Pirzada, M M Kapoor.   

Abstract

193 patients (142 adults and 51 children) with acute PSGN were followed long term. Sixty percent had elevated serum creatinine and 14% had nephrotic range proteinuria at the onset. By two years 28 patients (14%) had died from uremia, and 19 were lost to follow up. Amongst the remainder, 8 patients (4%) had developed mild to moderate renal insufficiency, 12% were hypertensive, and 22% had urinary abnormalities. Of the 146 patients alive at 2 years, 107 were followed up to 10 years (mean 4.8 years). In addition to the 8 patients with renal insufficiency at 2 years, another 7 developed renal failure subsequently. Four out of these 15 patients progressed to uremia within 4 to 10 years after the onset of disease. Hypertension and persistent urinary abnormalities were present in 15% and 24% respectively. Progression to uremia occurred in 6% of children and 20% of adults. Nephrotic range proteinuria, renal insufficiency at the onset, and crescents in more than one third of glomeruli indicated a poor prognosis.

Entities:  

Mesh:

Year:  1987        PMID: 3610371

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  3 in total

1.  Acute reversible changes of brachial-ankle pulse wave velocity in children with acute poststreptococcal glomerulonephritis.

Authors:  Mei-Ching Yu; Mei-Shiuan Yu; Meng-Kung Yu; Fan Lee; Wen-Hung Huang
Journal:  Pediatr Nephrol       Date:  2010-07-18       Impact factor: 3.714

2.  Clinicopathological study of infection-associated glomerulonephritis in adults.

Authors:  Yao-Ko Wen
Journal:  Int Urol Nephrol       Date:  2009-08-11       Impact factor: 2.370

3.  Outcome of severe acute post-streptococcal glomerulonephritis in New Zealand children.

Authors:  William Wong; Maxwell Clarke Morris; Jonathan Zwi
Journal:  Pediatr Nephrol       Date:  2008-12-19       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.